This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development.
Cascioferro, S., Parrino, B., Spano', V., Carbone, A., Montalbano, A., Barraja, P., et al. (2017). 1,3,5-Triazines: A promising scaffold for anticancer drugs development. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 142, 523-549 [10.1016/j.ejmech.2017.09.035].
Data di pubblicazione: | 2017 | |
Titolo: | 1,3,5-Triazines: A promising scaffold for anticancer drugs development | |
Autori: | ||
Citazione: | Cascioferro, S., Parrino, B., Spano', V., Carbone, A., Montalbano, A., Barraja, P., et al. (2017). 1,3,5-Triazines: A promising scaffold for anticancer drugs development. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 142, 523-549 [10.1016/j.ejmech.2017.09.035]. | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.ejmech.2017.09.035 | |
Abstract: | This review covering literature reports from the beginning of this century to 2016 describes the synthetic pathways, the antitumor activity, the structure-activity relationship and, whenever reported, the possible mechanism of action of 1,3,5-triazine derivatives as well as of their hetero-fused compounds. Many 1,3,5-triazine derivatives, both uncondensed and hetero-fused, have shown remarkable antitumor activities and some of them reached clinical development. | |
URL: | http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/ | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
E. J. Med. Chem. 142 (2017) 523-549.pdf | N/A | Administrator Richiedi una copia |